Mutant-allele tumor heterogeneity in malignant glioma effectively predicts neoplastic recurrence

Intra-tumor heterogeneity (ITH) is one of the most important causes of therapy resistance, which eventually leads to the poor outcomes observed in patients with glioma. Mutant-allele tumor heterogeneity (MATH) values are based on whole-exon sequencing and precisely reflect genetic ITH. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Pengfei, Yang, Wei, Ma, Jianxing, Zhang, Jingyu, Liao, Maojun, Xu, Lunshan, Xu, Minhui, Yi, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865645/
https://www.ncbi.nlm.nih.gov/pubmed/31788085
http://dx.doi.org/10.3892/ol.2019.10978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865645/
https://www.ncbi.nlm.nih.gov/pubmed/31788085
http://dx.doi.org/10.3892/ol.2019.10978

Ejemplares similares